[The effect of oral synthetic protease inhibitor (FOY 305) on endocrine pancreas and carbohydrate and lipid metabolism in normal and streptozotocin-induced diabetic rats].

MLA

Eto, M., et al. “[The Effect of Oral Synthetic Protease Inhibitor (FOY 305) on Endocrine Pancreas and Carbohydrate and Lipid Metabolism in Normal and Streptozotocin-Induced Diabetic Rats].” Nihon Naibunpi Gakkai Zasshi, vol. 60, no. 5, May 1984, pp. 684–95. EBSCOhost, https://doi.org/10.1507/endocrine1927.60.5_684.

APA

Eto, M., Watanabe, K., Kagaya, T., Sakai, Y., Yoshida, S., Oyama, K., Futaki, G., Saito, T., Takebe, T., & Ishii, K. (1984). [The effect of oral synthetic protease inhibitor (FOY 305) on endocrine pancreas and carbohydrate and lipid metabolism in normal and streptozotocin-induced diabetic rats]. Nihon Naibunpi Gakkai Zasshi, 60(5), 684–695. https://doi.org/10.1507/endocrine1927.60.5_684

Chicago

Eto, M, K Watanabe, T Kagaya, Y Sakai, S Yoshida, K Oyama, G Futaki, T Saito, T Takebe, and K Ishii. 1984. “[The Effect of Oral Synthetic Protease Inhibitor (FOY 305) on Endocrine Pancreas and Carbohydrate and Lipid Metabolism in Normal and Streptozotocin-Induced Diabetic Rats].” Nihon Naibunpi Gakkai Zasshi 60 (5): 684–95. doi:10.1507/endocrine1927.60.5_684.